M. Baykara Et Al. , "CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Vienna, Austria, pp.227, 2012
Baykara, M. Et Al. 2012. CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS. 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Vienna, Austria), 227.
Baykara, M., Benekli, M., Ekinci, O., Coskun, U., Eser, E. P., Polat, O., ... Demirci, U.(2012). CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.227). Vienna, Austria
Baykara, M. Et Al. "CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 2012
Baykara, M. Et Al. "CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.227, 2012
Baykara, M. Et Al. (2012) . "CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, p.227.
@conferencepaper{conferencepaper, author={M. Baykara Et Al. }, title={CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Vienna}, country={Austria}, year={2012}, pages={227} }